Navigation Links
Hospira Launches Generic Irinotecan Injection
Date:2/27/2008

- Offers Unique Formulation of Important Cancer Medication -

LAKE FOREST, Ill., Feb. 27 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, today announced the launch of irinotecan hydrochloride injection in the United States. The medication is a generic version of Pfizer's Camptosar(R), which posted 2007 U.S. sales of more than $545 million. Irinotecan hydrochloride injection is used for patients with colon or rectal cancer whose disease has recurred or progressed following therapy with other treatments.

"We are continuing to grow our leading portfolio of generic medications used to treat patients with cancer," said Robert Felicelli, vice president and general manager, Specialty Pharmaceuticals, Hospira. "By providing irinotecan and other high-quality, lower-cost alternatives to proprietary medications, Hospira is meeting patient needs in this fast-growing therapeutic area."

Hospira's irinotecan product portfolio extends beyond the formulations available from the innovator. In addition to offering the medication in 40 mg and 100 mg single-dose vials, Hospira is also marketing a 500 mg single-dose vial, for additional convenience when preparing and delivering larger doses. The company packages irinotecan in its proprietary Onco-Tain(TM) vials for safe handling.

Hospira offers the broadest generic injectable product portfolio in the world, with more than 190 generic injectable products in more than 900 dosages and formulations. Product areas include cardiovascular, anesthesia, anti-infectives, oncology, analgesics, emergency and other therapeutic segments. A host of proprietary non-biologic drugs are facing patent expiration globally over the coming yea
'/>"/>

SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
2. Hospira Hosts Conference Call for Fourth-Quarter 2007 Results and 2008 Projections
3. Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9
4. Hospira Reports Third-Quarter 2007 Results
5. Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13
6. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
7. eDiets(R) Launches Fresh Meal Delivery Program for alli(R) Users
8. AthletixNation.com Launches Sports Website and Community Programs
9. ARJO, Inc. Launches Two Innovative Products and New Campaign
10. Specialty European Pharma launches plenaxis in Germany
11. GO3 Launches Line of Health-Focused Products with Partner David Beckham
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... commonly used to treat glaucoma may cause droopy eyelids ... according to a new study. The drugs, known ... eye pressure, have already been shown to cause blurred ... said, suggesting that the new findings could lead to ... conservative when prescribing these drugs, the researchers added, particularly ...
(Date:5/24/2013)... New York (PRWEB) May 24, 2013 Let’s ... teeth. It is not uncommon for the majority of people ... Whether it is due to a coffee addiction or simply ... why whitening procedures are so popular. , Herald ... new and very effective whitening system: Venus White Max. ...
(Date:5/24/2013)... 2013 Area homeowners dreaming about owning a ... tubs to choose from at factory-direct pricing during the ... event takes place at Emerald Pool and Patio ... Jacuzzi, the industry's leading hot tub brand, scheduled the event ... The event will feature popular hot tub models at up ...
(Date:5/24/2013)... May 24, 2013 The nation’s first ... Intuitive Surgical Inc.’s da Vinci Surgical System concluded yesterday, ... a Washington State Court jury ruled in a 10-to-2 ... a surgeon who performed a da Vinci prostatectomy on ... patient’s family had alleged in their lawsuit that the ...
(Date:5/24/2013)... infantile myofibromatosis (IM)a disorder characterized by multiple tumors involving ... targets, according to researchers from the Icahn School of ... American Journal of Human Genetics , may lead ... which the only current treatment option is repeated surgical ... disorder that develops in infancy or even in utero ...
Breaking Medicine News(10 mins):Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 3Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2
... transplantation reliably yield grafts for two adults? Experts consider ... the July issue of Liver Transplantation , a ... also available online at Wiley Interscience ( www.interscience.wiley.com ). ... advanced surgical strategies to increase opportunities for those in ...
... , ... ROUND ROCK, Texas (Business Wire EON) June 30, ... the mantra that ,more is better, when it comes to managing ... Life Sciences. "Virtualizing the IT infrastructure fully illustrates the idea that ...
... PLANTATION, Fla., June 30 To further growth ... service and,medical management operations, Broadspire has made several ... -- Dennis Replogle, currently chief executive officer, becomes ... currently president of Broadspire, also will,assume the responsibilities ...
... PRUSSIA, Pa., June 30 TMG Health announced,today that ... of the,Ernst & Young Entrepreneur Of The Year(R) 2008 ... the awards program was designed to,recognize outstanding entrepreneurs on ... leading dynamic, growing businesses. Jack Tighe,was selected as a ...
... Declaration Survey, SEOUL, Korea, June 30 ... the workplace and keeping,it top of mind with ... keeping employees safe, according to a DuPont-sponsored survey ... The survey results are the basis for the ...
... FORT WORTH, Texas, June 30 Wound Management,Technologies, ... signing,of a commission based, sales agreement for its ... (EWA GSI). This agreement,follows discussions and demonstrations, and ... role in international wound management.,CellerateRx patented collagen fragments ...
Cached Medicine News:Health News:Experts examine challenges of split liver transplantation 2Health News: Virtualization with Dell Helps Cure Growing Health Care IT Ills 2Health News: Virtualization with Dell Helps Cure Growing Health Care IT Ills 3Health News: Virtualization with Dell Helps Cure Growing Health Care IT Ills 4Health News:Broadspire Announces Key Leadership Appointments 2Health News:Broadspire Announces Key Leadership Appointments 3Health News:TMG Health President and CEO Jack Tighe Named Ernst & Young Entrepreneur Of The Year(R) 2008 in Philadelphia Region 2Health News:TMG Health President and CEO Jack Tighe Named Ernst & Young Entrepreneur Of The Year(R) 2008 in Philadelphia Region 3Health News:Companies Report Success in Driving Safety Culture at Workplaces 2Health News:Companies Report Success in Driving Safety Culture at Workplaces 3Health News:Companies Report Success in Driving Safety Culture at Workplaces 4Health News:Wound Management Technologies, Inc. Announces Sales Agreement with EWA Government Systems, Inc. 2Health News:Wound Management Technologies, Inc. Announces Sales Agreement with EWA Government Systems, Inc. 3
(Date:5/23/2013)... 2013 More than half of women diagnosed ... chemotherapy and still have excellent outcomes. To educate women, ... the largest sources of online consumer information about breast ... page provide recently diagnosed women with information sources, to ... "We anticipate these innovative social media campaigns ...
(Date:5/23/2013)... , May 23, 2013  Hologic, Inc. ... ), a leading developer, manufacturer and supplier of ... with an emphasis on serving the healthcare needs ... observational study in a U.S. clinical practice comparing ... (breast tomosynthesis) with conventional 2D mammography alone showed ...
(Date:5/23/2013)...  BioElectronics Corporation (OTC Pink: BIEL), the maker of ... FDA panel meeting for non-thermal shortwave diathermy: ... Therapy Meeting was held on May 21, 2013 in ... of the meeting was very narrow, in that the ... the application of non-thermal shortwave diathermy for the treatment ...
Breaking Medicine Technology:Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 2Agendia Launches Social Media Campaigns to Help Breast Cancer Patients with Chemotherapy Decisions 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4BioElectronics and Pulsed Shortwave Therapy Make Progress 2
Knot pusher/suture retriever...
Single step suture passage is made simple with Arthro-Pierce instruments. The low profile, highly sharpened tip allows easy passage through tissue in order to retrieve or apply suture....
Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
Arthrex has the most extensive offering of arthroscopic suture passing instruments,available anywhere in the world. We have speci? cally designed the function of our,instruments to work hand in hand ...
Medicine Products: